Kenneth A. Fields - Concepedia

Author

Kenneth A. Fields

University of Miami ORCID

Also Known As

K A Fields, K. A. Fields, K. Fields, K.A. Fields, Kenneth A. Fields, Kenneth A Fields, Kenneth A. Fields

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University of Miami University of Kentucky National Institute of Allergy and Infectious Diseases Albert B. Chandler Hospital University of Central Florida

About

Kenneth A. Fields is an author at University of Miami specializing in medicine, pathogenesis, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.6K
2	Natural Sciences	6	6	770
3	Health Sciences	2	2	48
4	Engineering	1	1	12
5	Public Health	1	1	177

Kenneth A. Fields

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin Dawn R. Clifton, Kenneth A. Fields, Scott S. Grieshaber, Proceedings of the National Academy of Sciences	2004	410
Three temporal classes of gene expression during the <i>Chlamydia trachomatis</i> developmental cycle Edward I. Shaw, Cheryl A. Dooley, Elizabeth R. Fischer, Molecular Microbiology GeneticsBacteriologyTemporal Gene ExpressionMolecular BiologyBacteriophage	2000	276
Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci Manuel F. Rosado, Gerald E. Byrne, Feying Ding, Blood	2005	205
<i>Chlamydia trachomatis</i> type III secretion: evidence for a functional apparatus during early‐cycle development Kenneth A. Fields, David J. Mead, Cheryl A. Dooley, Molecular Microbiology Protein SecretionImmunologyBacteriologyGynecologyBacterial Pathogenesis	2003	177
Evidence for the secretion of <i>Chlamydia trachomatis</i> CopN by a type III secretion mechanism Kenneth A. Fields, Ted Hackstadt Molecular Microbiology Secretion Pore ComponentsType Iii MechanismMedical MicrobiologyFull VirulenceVirulence Factor	2000	163
Treatment of <i>Chlamydia trachomatis</i> with a small molecule inhibitor of the <i>Yersinia</i> type III secretion system disrupts progression of the chlamydial developmental cycle Katerina Wolf, Helen J. Betts, Blandine Chellas-Géry, Molecular Microbiology	2006	158
Eukaryotic Initiation Factor 2 (eIF2) Signaling Regulates Proinflammatory Cytokine Expression and Bacterial Invasion Niraj Shrestha, Wael Bahnan, David J. Wiley, Journal of Biological Chemistry	2012	143
Virulence Role of V Antigen of<i>Yersinia pestis</i>at the Bacterial Surface Kenneth A. Fields, Matthew L. Nilles, Clarissa Cowan, Infection and Immunity Pathogenic MicrobiologyMicrobial PathogensTruncated Lcrv ProteinsImmunologyBacterial Pathogens	1999	137
Tyrosine Phosphorylation of the Chlamydial Effector Protein Tarp Is Species Specific and Not Required for Recruitment of Actin Dawn R. Clifton, Cheryl A. Dooley, Scott S. Grieshaber, Infection and Immunity Protein SecretionMicrobial PathogensObligate Intracellular PathogensBacteriologyMolecular Biology	2005	123
Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis Konrad Mueller, Katerina Wolf, Kenneth A. Fields mBio	2016	117

Page 1